Vimarsana
Biggest News Aggregation in the World

Page 3 - Precision Flow Plus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Precision Flow Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Precision Flow Plus Today - Breaking & Trending Today

Head to Head Analysis: Artivion (NYSE:AORT) & Vapotherm (NYSE:VAPO) - Vimarsana News

Head to Head Analysis: Artivion (NYSE:AORT) & Vapotherm (NYSE:VAPO)

Vapotherm (NYSE:VAPO – Get Rating) and Artivion (NYSE:AORT – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, valuation, earnings and analyst recommendations. Valuation & Earnings This table compares Vapotherm and Artivion’s gross revenue, […]

Vapotherm, Inc. (VAPO) Q3 2022 Earnings Call Transcript - Vimarsana News

Vapotherm, Inc. (VAPO) Q3 2022 Earnings Call Transcript

Vapotherm, Inc. (NYSE:NYSE:VAPO) Q3 2022 Earnings Conference Call November 2, 2022 16:30 ET Company Participants Mark Klausner - Westwicke Partners Joe Army - President & Chief...

Vapotherm, Inc. (VAPO) CEO Joe Army on Q2 2022 Results - Earnings Call Transcript - Vimarsana News

Vapotherm, Inc. (VAPO) CEO Joe Army on Q2 2022 Results - Earnings Call Transcript

Vapotherm, Inc. (NYSE:NYSE:VAPO) Q2 2022 Earnings Conference Call August 03, 2022 04:30 PM ET Company Participants Mark Klausner - Westwicke Partners Joe Army - President and Chief...

Head to Head Review: Vapotherm (NYSE:VAPO) & Alphatec (NASDAQ:ATEC) - Vimarsana News

Head to Head Review: Vapotherm (NYSE:VAPO) & Alphatec (NASDAQ:ATEC)

Vapotherm (NYSE:VAPO – Get Rating) and Alphatec (NASDAQ:ATEC – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings. Institutional and Insider Ownership 69.7% of Vapotherm shares are held by […]

Vapotherm, Inc. (NYSE:VAPO) Expected to Post Quarterly Sales of $19.34 Million - Vimarsana News

Vapotherm, Inc. (NYSE:VAPO) Expected to Post Quarterly Sales of $19.34 Million

Wall Street analysts predict that Vapotherm, Inc. (NYSE:VAPO – Get Rating) will post sales of $19.34 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Vapotherm’s earnings, with the highest sales estimate coming in at $19.98 million and the lowest estimate coming in at $18.70 million. Vapotherm posted […]